A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury. (2022)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-022-06244-6
PubMed Identifier: 35505387
Publication URI: http://europepmc.org/abstract/MED/35505387
Type: Journal Article/Review
Volume: 23
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215